<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Patients with <z:mp ids='MP_0002055'>diabetes</z:mp> who manifest <z:hpo ids='HP_0000093'>proteinuria</z:hpo> are at increased risk for cardiovascular events </plain></SENT>
<SENT sid="1" pm="."><plain>Some studies suggest that <z:hpo ids='HP_0000093'>proteinuria</z:hpo> exerts its cardiovascular effects at least partly through a positive association with total plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (tHcy) </plain></SENT>
<SENT sid="2" pm="."><plain>Modestly sized but better designed contrary studies find no such link through a limited range of serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We tested the hypothesis that <z:hpo ids='HP_0000093'>proteinuria</z:hpo> independently predicts tHcy levels in a larger cohort of type 2 diabetic patients with <z:hpo ids='HP_0000112'>nephropathy</z:hpo> throughout a much broader range of <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESEARCH DESIGN AND METHODS: Baseline data for the cross-sectional study were obtained from 717 patients enrolled in the multicenter <z:chebi fb="0" ids="5959">Irbesartan</z:chebi> Diabetic <z:hpo ids='HP_0000112'>Nephropathy</z:hpo> Trial </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects had type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and were between 29 and 78 years of age </plain></SENT>
<SENT sid="6" pm="."><plain>Data included age, sex, BMI, serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> and albumin, <z:chebi fb="15" ids="39026">LDL</z:chebi> and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, <z:chebi fb="0" ids="17855">triglyceride</z:chebi>, <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and <z:mp ids='MP_0002871'>albuminuria</z:mp>, plasma <z:chebi fb="3" ids="37445">folate</z:chebi>, <z:chebi fb="13" ids="33611">B12</z:chebi>, and <z:chebi fb="0" ids="18405">pyridoxal 5'-phosphate</z:chebi> (PLP) (the active form of B6), HbA(1c), and tHcy levels </plain></SENT>
<SENT sid="7" pm="."><plain>Unadjusted and multivariable models were used in the analysis </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Crude analyses revealed significant associations between tHcy and age (r = 0.074; P = 0.008), <z:chebi fb="0" ids="16737">creatinine</z:chebi> (r = 0.414; P &lt; 0.001), PLP (r = -0.105; P = 0.021), <z:chebi fb="13" ids="33611">B12</z:chebi> (r = -0.216; P &lt; 0.001), <z:chebi fb="3" ids="37445">folate</z:chebi> (r = -0.241; P &lt; 0.001), and HbA(1c) (r = -0.119; P = 0.003), with serum albumin approaching significance (r = 0.055; P = 0.072) </plain></SENT>
<SENT sid="9" pm="."><plain>Only serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, plasma <z:chebi fb="3" ids="37445">folate</z:chebi>, <z:chebi fb="13" ids="33611">B12</z:chebi>, serum albumin, sex, HbA(1c), and age were independent predictors of tHcy after controlling for <z:hpo ids='HP_0000001'>all</z:hpo> other variables </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: By finding no independent correlation between <z:hpo ids='HP_0000093'>proteinuria</z:hpo> (or <z:mp ids='MP_0002871'>albuminuria</z:mp>) and tHcy levels, this study improves the external validity of previous negative findings </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, it is unlikely that the observed positive association between <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> is directly related to <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> </plain></SENT>
</text></document>